Company: HCTI
Filing Date: 2025-05-08
Form Type: CORRESP
Source: 0001213900-25-041191
Chunk: 0

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-08
Form: CORRESP
Chunk 0
---
May 8, 2025

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Technology

100 F. Street, NE

Washington, D.C. 20549

| Attention: | Aliya Ishmukhamedova / Matthew Crispino |

| Re: | Healthcare Triangle, Inc.                             
 Amendment No. 2 to Registration Statement on Form S-1 
 Originally Submitted on April 1, 2025                 
 File No. 333-286331                                   |

Ladies and Gentlemen:

On behalf of Healthcare Triangle,
Inc. (the “Company”), and pursuant to the applicable provisions of the Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations promulgated thereunder, we are submitting with the Securities and Exchange Commission (the
“Commission”), via EDGAR, Amendment No. 2 to the Registration Statement on Form S-1 (the “Amended Registration Statement”), which reflects revisions to Amendment No.1 to the above-referenced Registration Statement filed with the Commission
on April 22, 2025 (the “Prior Amendment” and together with the Amended Registration Statement and the Registration Statement
originally filed on April 1, 2025, hereinafter referred to as the “Registration Statement”). The Registration Statement
has been revised in response to the comment letter addressed to the Company dated April 15, 2025, from the staff of the Commission (the
“Staff”), as well as certain other updated information.

Capitalized terms used but
not otherwise defined herein have the meanings set forth in the Amended Registration Statement.

For reference purposes, the
comments contained in the Staff’s letter dated May 5, 2025, are reproduced below in italics and the corresponding responses are
shown below the comments. All references to page numbers in the Company’s responses are to the page numbers in the Registration
Statement.

| 1. | Staff Comment: We note that you have received a notice of delisting from Nasdaq due to failure to maintain a minimum bid price for your company's securities. Disclose whether the Securities Purchase Agreements were entered into to avoid delisting, and the risks that the offering may not result in the Company's securities remaining listed on the Nasdaq. We also note that at least one other company has recently attempted a similar offering including warrants with zero exercise price to maintain Nasdaq listing. The company has disclosed that Nas